Skip to Content Skip to Navigation

About us Practical matters How to find us dr. L.A. (Lisa) de Jong

dr. L.A. (Lisa) de Jong

Postdoctoral Researcher Global Health Economics

Faculty of Medical Sciences

Telephone:

E-mail:

l.a.de.jong rug.nl

ORCID Research Portal

Research interests

Lisa has a background in pharmacy and conducted her doctoral research 'Health economics of direct oral anticoagulants in the Netherlands' at the department of Pharmacotherapy, -epidemiology, and -economics — University of Groningen. Her research focusses on health economic modelling for reimbursement and clinical decision-making purposes, with special interest in using real-world data to populate models and expertise in cardiorenal metabolic diseases. Currently, Lisa is involved in various research projects and technical appraisals for the National Institute for Health and Care Excellence in the UK. Expertise: pharmacoeconomics, health economics, burden of disease, budget impact, health technology assessment, cost-effectiveness.

Publications

Early economic evaluation of chelation therapy in kidney transplant recipients with high-normal lead

Hao, J., Alizadeh, B. Z., Postma, M. J., Touw, D. J., Bakker, S. J. L. & de Jong, L. A., 27-Feb-2025, In: PLoS ONE. 20, 2, 23 p., e0319022.

Research output: Contribution to journal › Article › Academic › peer-review

Lung cancer screening with volume computed tomography is cost-effective in Greece

Pan, X., Togka, K., Ten Berge, H., de Jong, L., Groen, H., Postma, M. J., Zervas, E., Gkiozos, I., Foroulis, C., Tavernaraki, K., Lampaki, S., Kourlaba, G., Moraris, A., Agelaki, S. & Syrigos, K., 5-Mar-2025, In: PLoS ONE. 20, 3, 18 p., e0316351.

Research output: Contribution to journal › Article › Academic › peer-review

A Systematic Review of Health-Related Quality of Life in Women with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab

Khoirunnisa, S. M., Suryanegara, A., de Jong, L., Setiawan, D. & Postma, M., Jul-2024, In: PharmacoEconomics - open. 8, p. 511–524 14 p.

Research output: Contribution to journal › Review article › peer-review

Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland

Paulissen, J. H. J., Seddik, A. H., Dunton, K. J., Livings, C. J., van Hulst, M., Postma, M. J., de Jong, L. A. & Freriks, R. D., Aug-2024, In: European Journal of Health Economics. 25, p. 689–699 11 p.

Research output: Contribution to journal › Article › Academic › peer-review

Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands

Slob, B., Fens, T., Weersma, M., Postma, M., Boersma, C. & de Jong, L., 10-Dec-2024, In: PLoS ONE. 19, 12, 16 p., e0315509.

Research output: Contribution to journal › Article › Academic › peer-review

Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies: can alignment be improved?

Wolters, S., de Jong, L. A., Jansen, C., Jansman, F. G. A. & Postma, M. J., 2024, In: Expert Review of Pharmacoeconomics and Outcomes Research. 24, 2, p. 251-265 15 p.

Research output: Contribution to journal › Article › Academic › peer-review

Economic evaluation of trastuzumab in HER2-positive early breast cancer in Indonesia: A cost-effectiveness analysis

Khoirunnisa, S. M., Suryanegara, F. D. A., Setiawan, D., Postma, M. J. & de Jong, L. A., May-2024, In: PLoS ONE. 19, 5, 16 p., e0304483.

Research output: Contribution to journal › Article › Academic › peer-review

Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data

de Jong, L. A., Li, X., Emamipour, S., van der Werf, S., Postma, M. J., van Dijk, P. R. & Feenstra, T. L., Sept-2024, In: Pharmacoeconomics. 42, p. 929–953 25 p.

Research output: Contribution to journal › Review article › peer-review

Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran

Fens, T., de Jong, L., Kappelhoff, B., Boersma, C. & Postma, M. J., 2023, In: Journal of Market Access and Health Policy. 11, 1, 16 p., 2247719.

Research output: Contribution to journal › Article › Academic › peer-review

Cost-Effectiveness Models of Continuous Glucose Monitoring in Individuals With Type 1 Diabetes: A Systematic Review on Methodology and Quality

de Jong, L., Li, X., Emamipour, S., van der Werf, S., Postma, M., van Dijk, P. R. & Feenstra, T. L., Dec-2023, In: Value in Health. 26, 12, Supplement, p. S196 1 p.

Research output: Contribution to journal › Meeting Abstract › Academic

All (27) publications

View full research profile

Follow the UGfacebook linkedin rss instagram youtube